Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel Disease.
Simone E JaenischCatherine A AbbottMark D GorrellPeter BamptonRoss N ButlerRoger YazbeckPublished in: Clinical and translational gastroenterology (2022)
Our findings implicate the DPP enzyme family in intestinal inflammation and suggest future biomarker applications to differentiate the pathophysiological aspects of IBD.